Amikacin
- TRADE NAMES: Amicacina; Amicasil; Amikacin sulfate (Bedford); Amikan; Biclin; Biklin; Gamikal; Kanbine; Lukadin; Miacin; Yectamid
- INDICATIONS: Short-term treatment of serious infections due to gram-negative bacteria
- CLASS: Antibiotic, Antibiotic; aminoglycoside, Antimicrobial, Drug-resistant antituberculosis agent
- HALF-LIFE: 1.5–2.5 hours (adults)
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adefovir, Aldesleukin, Aminoglycosides, Atracurium, Bumetanide, Cephalexin, Doxacurium, Ethacrynic Acid, Furosemide, Succinylcholine, Teicoplanin, Torsemide
PREGNANCY CATEGORY: D
Aminoglycosides may cause neurotoxicity and/or nephrotoxicity.
Please login to see the rest of this drug profile
SKIN.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
